Anticancer effects of combinational treatment with BRAF(V600E) siRNA and PI3K pathway inhibitors in melanoma cell lines harboring BRAF(V600E)

He, HY; Nan, XY; Liu, S; Zhang, LR; Yang, ZJ; Wu, Y; Zhang, LH

Yang, ZJ; Wu, Y (reprint author), Peking Univ, State Key Lab Nat & Biomimet Drugs, Sch Pharmaceut Sci, 38 Xueyuan Rd, Beijing 100191, Peoples R China.

ONCOLOGY LETTERS, 2018; 16 (1): 632

Abstract

In the present study, the anti-tumor effects of combination treatment with an siRNA targeting B-Raf proto-oncogene serine/threonine kinase (BRAF)(V600......

Full Text Link


Links

期刊讨论 | 中国SCI论文 | 期刊主页 | 投稿经验 | 杂志官网 | 投稿链接 | 作者需知 | PMC链接 | Pubmed全文检索